![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEW
Minerva Ortopedica e Traumatologica 2020 June;71(2):68-71
DOI: 10.23736/S0394-3410.19.03961-4
Copyright © 2019 EDIZIONI MINERVA MEDICA
language: English
Glucocorticoid myopathy: pathogenesis and essential nature
Teet SEENE ✉, Priit KAASIK
Institute of Sport Sciences and Physiotherapy, University of Tartu, Tartu, Estonia
Reasons of glucocorticoids-induced myopathy are high level of blood corticosteroids, structural changes in fast twitch (FT) skeletal muscle fibers, decreased protein synthesis and increased protein degradation rate, slow turnover rate of contractile proteins and slow regeneration capacity of muscle tissue due to the decrease in the number of satellite cells under the basal lamina of muscle fibers. In addition disarray of myofibrils, which begins from peripheral myosin filaments of FT glycolytic muscle fibers, and changes in neuromuscular junctions, are leading to development of muscle atrophy and weakness.
KEY WORDS: Myotoxicity; Muscular atrophy; Muscle weakness